The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice

Journal of Clinical Investigation

Volumn 119, Issue 11, 2009, Pages 3373-3383

  Weidemann, Alexander ^a   Kerdiles, Yann M ^a   Knaup, Karl X ^b   Rafie, Christopher A ^a   Boutin, Adam T ^a   Stockmann, Christian ^a   Takeda, Norihiko ^a   Scadeng, Miriam ^c   Shih, Andy Y ^a   Haase, Volker H ^d   Simon, M Celeste ^e   Kleinfeld, David ^a   Johnson, Randall S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Nikolaus Fiebiger Center for Molecular Medicine   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; VON HIPPEL LINDAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL FUNCTION; CONTROLLED STUDY; ERYTHROPOIESIS; GENE DELETION; GENE TARGETING; GLIA CELL; HYPOXIA; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; STEM CELL;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ERYTHROPOIESIS; GENE DELETION; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEUROGLIA; PHENOTYPE; RECOMBINATION, GENETIC; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70449412497     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39378     Document Type: Article

References (52)

1. Jelkmann, W. 1992. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72:449-489.
2. Viault, F. 1890. Sur l'augmentation considerable du nombre des globules rouges dans le sang chez le habitants des hautes plateaux de l'Amerique du Sud. C.R. Acad. Sci. Paris. 111:918-919.
3. Semenza, G.L., and Wang, G.L. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:5447-5454.
4. Weidemann, A., and Johnson, R.S. 2008. Biology of HIF-1alpha. Cell Death Differ. 15:621-627.
5. Wenger, R.H. 2002. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16:1151-1162.
6. Maxwell, P.H., et al. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:271-275.
7. Fandrey, J. 2004. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R977-R988. (Pubitemid 38661383)
8. Weidemann, A., and Johnson, R.S. 2009. Nonrenal regulation of EPO synthesis. Kidney Int. 75:682-688.
9. Jacobson, L.O., Goldwasser, E., Fried, W., and Plzak, L. 1957. Role of the kidney in erythopoiesis. Nature. 179:633.
10. Carnot, P., and Deflandre, C. 1906. Sur l'activité hémopoiétique des différents organes au cours de la régénération du sang. C. R. Acad. Sci. Paris. 143:432-435.
11. Tan, C.C., Eckardt, K.U., Firth, J.D., and Ratcliffe, P.J. 1992. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am. J. Physiol. 263:F474-F481.
12. Dame, C., Juul, S.E., and Christensen, R.D. 2001. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate. 79:228-235. (Pubitemid 32247092)
13. Brines, M.L., et al. 2000. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97:10526-10531.
14. Marti, H.H. 2004. Erythropoietin and the hypoxic brain. J. Exp. Biol. 207:3233-3242.
15. Bernaudin, M., et al. 2000. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia. 30:271-278. (Pubitemid 30259666)
16. Masuda, S., et al. 1994. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269:19488-19493. (Pubitemid 24978761)
17. Marti, H.H., et al. 1996. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:666-676. (Pubitemid 26114611)
18. Chavez, J.C., Baranova, O., Lin, J., and Pichiule, P. 2006. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J. Neurosci. 26:9471-9481. (Pubitemid 44396860)
19. Rossi, D.J., Brady, J.D., and Mohr, C. 2007. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10:1377-1386. (Pubitemid 350014689)
20. Bajenaru, M.L., et al. 2002. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell. Biol. 22:5100-5113.
21. Ryan, H.E., Lo, J., and Johnson, R.S. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005-3015. (Pubitemid 28254373)
22. Gruber, M., et al. 2007. Acute postnatal ablation of Hif-2alpha results in anemia. Proc. Natl. Acad. Sci. U. S. A. 104:2301-2306. (Pubitemid 46391392)
23. Haase, V.H., Glickman, J.N., Socolovsky, M., and Jaenisch, R. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 98:1583-1588. (Pubitemid 32165542)
24. Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., and Kaelin, W.G., Jr. 2002. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 1:237-246.
25. Maranchie, J.K., et al. 2002. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 1:247-255.
26. Kondo, K., Kim, W.Y., Lechpammer, M., and Kaelin, W.G., Jr. 2003. Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1:E83.
27. Rankin, E.B., et al. 2008. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene. 27:5354-5358.
28. Brodsky, I., Dennis, L.H., Kahn, S.B., and Brady, L.W. 1966. Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis. Cancer Res. 26:198-201.
29. Gerber, H.P., et al. 1999. VEGF is required for growth and survival in neonatal mice. Development. 126:1149-1159.
30. Cramer, F., and Kimsey, M.W. 1952. The cerebellar hemangioblastomas; review of fifty-three cases with special reference to cerebellar cysts and the association of polycythemia. AMA Arch. Neurol. Psychiatry. 67:237-252.
31. Waldmann, T.A., Levin, E.H., and Baldwin, M. 1961. The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoiesis stimulating factor by the tumor. Am. J. Med. 31:318-324.
32. Kuhne, M., Sidler, D., Hofer, S., Lugli, A., and Ludwig, C. 2004. Challenging manifestations of malignancies. Case 1. Polycythemia and high serum erythropoietin level as a result of hemangioblastoma. J. Clin. Oncol. 22:3639-3640.
33. Lecuire, J., et al. 1972. Left temporal glioblastoma associated with polyglobulia [In French]. J. Med. Lyon. 53:559-563.
34. Seip, M., Halvorsen, S., Andersen, P., and Kaada, B.R. 1961. Effects of hypothalamic stimulation on erythropoiesis in rabbits. Scand. J. Clin. Lab. Invest. 13:553-563.
35. Kell, J.F., Jr., Hoff, E.C., and Hennigar, G.R. 1960. Erythrocytosis or symptomatic polycythemia following chronic cerebral stimulation through indwelling electrodes. J. Neurosurg. 17:1028-1038.
36. Gilbert, H.S., and Silverstein, A. 1965. Neurogenic polycythemia. Report of a patient with transient erythrocytosis associated with occlusion of a middle cerebral artery, and review of the literature. Am. J. Med. 38:807-813.
37. Divoky, V., et al. 2001. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene. Proc. Natl. Acad. Sci. U. S. A. 98:986-991. (Pubitemid 32121174)
38. Wagner, K.F., et al. 2001. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood. 97:536-542.
39. Banks, W.A., et al. 2004. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur. J. Pharmacol. 505:93-101.
40. Kilbridge, T.M., Fried, W., and Heller, P. 1969. The mechanism by which plethora suppresses erythropoiesis. Blood. 33:104-113.
41. Necas, E., Zivny, J., and Neuwirt, J. 1972. Effect of polycythemia on erythropoietin production in the hypoxic rat. Am. J. Physiol. 223:809-811.
42. Rankin, E.B., et al. 2007. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117:1068-1077.
43. Boutin, A.T., et al. 2008. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell. 133:223-234.
44. Jones, M.D., Jr., Traystman, R.J., Simmons, M.A., and Molteni, R.A. 1981. Effects of changes in arterial O2 content on cerebral blood flow in the lamb. Am. J. Physiol. 240:H209-H215. (Pubitemid 11155916)
45. Ulatowski, J.A., Bucci, E., Razynska, A., Traystman, R.J., and Koehler, R.C. 1998. Cerebral blood flow during hypoxic hypoxia with plasma-based hemoglobin at reduced hematocrit. Am. J. Physiol. 274:H1933-H1942. (Pubitemid 28308812)
46. Chikuma, M., Masuda, S., Kobayashi, T., Nagao, M., and Sasaki, R. 2000. Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am. J. Physiol. Endocrinol. Metab. 279:E1242-E1248.
47. Weidemann, A., et al. 2008. HIF activation protects from acute kidney injury. J. Am. Soc. Nephrol. 19:486-494. (Pubitemid 351355392)
48. Weidemann, A., et al. 2008. Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem. J. 409:233-242.
49. Tsai, P.S., et al. 2003. All-optical histology using ultrashort laser pulses. Neuron. 39:27-41. (Pubitemid 36830946)
50. Nguyen, Q.T., Tsai, P.S., and Kleinfeld, D. 2006. MPScope: a versatile software suite for multiphoton microscopy. J. Neurosci. Methods. 156:351-359. (Pubitemid 44233677)
51. Drew, P.J., Blinder, P., Cauwenberghs, G., Shih, A.Y., and Kleinfeld, D. 2009. Rapid determination of particle velocity from space-time images using the Radon transform. J. Comput. Neurosci. Online publication ahead of print. doi:10.1007/s10827-009-0159-1.
52. Methia, N., et al. 2001. ApoE deficiency compromises the blood brain barrier especially after injury. Mol. Med. 7:810-815. (Pubitemid 34175304)